Use access key #2 to skip to page content.
$6.35 -0.14 (-2.16%)
5/16/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

1

Avatar Budsworth (94.41) Submitted: 4/26/08 6:27 AM : Outperform Start Price: $7.99 EXEL Score: -22.56

From all the recent chatter I've read, Exelis is in on some real good discoveries. May 15 there will be some announcements letting the rest of the world just how far they have come in their tumor blasting cancer drugs. Apparently, some larger pharmaceutical companies are pretty confident. A financial "shot -in-the-arm" has helped them move forward. This looks like a true bargain .I'm in.

Report this Post Replies: 0 | Reply

Featured Broker Partners